Daily Morning Note – 27 April 2022


Welcome to our Daily Morning Note from our Research team!


Stocks in Asia may come under pressure after U.S. shares sank with mixed earnings fueling concerns economic growth will slow down. The risk aversion sparked a jump in Treasuries and bolstered the dollar. Futures for Japan, Australia and Hong Kong fell, while U.S contracts wavered, after the S&P 500 slid to a six-week low and the technology-heavy Nasdaq 100 plumbed levels last seen in 2021. Meanwhile, Tesla’s valuation took a $126 billion hit as the stock fell 12% on investors’ concern that Elon Musk may sell shares to complete his $44 billion Twitter takeover.

China said it would step up infrastructure construction after a meeting chaired by President Xi Jinping, the latest pledge to bolster an economy that’s been hammered by a widening series of Covid-related lockdowns. The move came as mass testing for the virus kicked off in Beijing, sparking fears of a Shanghai-style lockdown. As the government takes ever-more extreme steps to stamp out transmission, one thing it hasn’t been able to do is create its own mRNA vaccine — possibly the country’s biggest Covid failure of all. Elsewhere, blood tests show well over half of the U.S. population has been infected with Covid-19 at some point.

Top gainers & losers




Frasers Centrepoint Trust 1H22 SPU rose 2.3% year on year to 6.136 cents. Gross revenue rose 1.5% year-on-year to $176.2 million on full contribution from the ARF acquisition and was partially offset by the loss of contribution from properties divested. NPI was up 3.8% year-on-year due to decrease in property expenses which arose from lower net allowance for doubtful debts and other property expenses in FY21. All properties in FCT’s portfolio registered better or steady occupancy quarter-on-quarter. The retail property portfolio registered improved committed occupancy of 97.8%, up 0.6 percentage-points from the previous quarter.

Mapletree Industrial Trust posts 5.8 % rise in Q4 FY22 DPU to 3.49 cents. Gross revenue was up 35.5 per cent to S$164.1 million for Q4 2022, from S$121.1 million a year ago. This was largely due to the revenue contribution from the acquisition of 29 data centres in the US in July 2021, and full quarter revenue from the data centre at Richmond, Virginia, acquired in March 2021, MIT’s manager said in a bourse filing. During the fourth quarter, average overall portfolio occupancy increased to 94 per cent from 93.6 per cent in the preceding quarter. This was due to the improved occupancy of MIT’s Singapore portfolio, which increased to 94.4 per cent from 93.7 per cent in the preceding quarter, as higher occupancies were registered for business park buildings and flatted factories.

Sheng Siong’s Q1 FY22 net profit up 13.9% year on year. Revenue for the quarter rose 6 per cent to S$358 million, from S$337.5 million a year ago. This was due to an increase in comparable same store sales by 4.7 per cent year-on-year in Singapore and 1 per cent year-on-year in China, it noted. It added that its new store in Singapore contributed 0.3 per cent increment to the total revenue increase. Sheng Siong has 64 stores in Singapore and 4 stores in China today. As inflationary pressures mount, Sheng Siong noted that consumers are “increasingly concerned with the higher cost of living and may choose to dine-in more at home,” which may continue to support sales at their supermarkets. Lim Hock Chee, Sheng Siong’s chief executive, also shared that the group secured the leases of 3 stores last year and is targeting to open 3 to 5 new stores per year for the next 3 to 5 years, with a focus on areas where it is not present in yet.

Sabana Reit unitholders vote against appointment of director Chan Wai Kheong at AGM. Chan, a hedge fund founder and former Credit Suisse trader, was appointed to the board of Sabana Reit in June last year. At an annual general meeting (AGM) on Apr 26, unitholders representing some 77 per cent of votes cast voted against Resolution 3 to endorse his appointment as a director of the Reit manager. Unitholders holding a total of 355.6 million units had voted in the resolution. Unitholders holding another 270.7 million units, including Sabana Reit’s major unitholder ESR Cayman and its concert parties, had abstained from voting in that resolution.

The 30-counter Straits Times Index (STI) is set for a shake-up later this week, with the smallest companies on the market barometer fighting to stay on the index. This has been triggered by index constituent Yangzijiang Shipbuilding : BS6 -2.17% (YZJ Shipbuilding), which is spinning off its investment arm into a separately listed entity. The shipbuilding segment remains in YZJ Shipbuilding while Yangzijiang Financial Holding (YZJFH) will list on Thursday (Apr 28). As a component of YZJ Shipbuilding, YZJFH will be included in the STI on day 1. Index provider FTSE Russell has announced that all constituents will be ranked by their full market capitalisations on Apr 28, and the smallest constituent will be removed effective May 5. Investors in the smallest STI counters should keep a close watch on the companies at risk of deletion, as passive index trackers would need to sell shares in the counter that gets deleted.


General Electric on Tuesday pegged its full-year earnings at the lower end of its previous forecast as the US industrial conglomerate was dogged by persistent supply chain disruptions and rising freight and raw material costs. Two years into the pandemic that has snarled supply chains across the globe and driven up costs for everything from labour to raw materials, companies are scrambling to produce enough to feed current demand and also to restock inventory shelves. In January, the company projected adjusted profit for the year to be in the range of US$2.80 to US$3.50 per share. It also expected to grow its profit margin by 150 basis points and to generate US$5.5 billion to US$6.5 billion in free cash flow.

JetBlue shares slump after airline drastically cuts 2022 growth plans. JetBlue is scaling back its 2022 growth plans to no more than 5% to avoid further flight disruptions. The airline previously said it expected to grow as much as 15% this year. Airlines have been forced to rethink growth plans as they grapple with weather delays, tight staffing and higher fuel costs.

Sales of new US homes drop to lowest in four months indicating high prices and surging borrowing costs are putting more of a squeeze on the market. Purchases of new single-family homes decreased 8.6 per cent to a 763,000 annualised pace, government data showed Tuesday. The median estimate in a Bloomberg survey of economists called for a 768,000 rate. Mortgage rates have sharply escalated as the Federal Reserve signals aggressive steps to combat decades-high inflation. The average for a 30-year loan climbed to 5.11 per cent last week, up two full percentage points from the end of last year and the highest since 2010, the latest Freddie Mac data show. The steep ascent in borrowing costs, combined with high home prices across markets, is sidelining more prospective buyers.

Pfizer and BioNTech on Tuesday asked the Food and Drug Administration to authorize a third dose of its Covid vaccine for children ages 5- to 11-years-old. The application comes after Pfizer released data earlier this month from a small lab study of blood samples from 30 kids in the age group, which showed a 36-fold increase in antibody levels against the omicron variant compared to two doses of the vaccine. The booster shot is a 10-microgram dose, the same level as the primary vaccination series for the age group. The third shot did not demonstrate any new safety concerns in the trial, according to Pfizer. Only about 28% of children ages 5 to 11 had received their primary series of two doses as of April, according to CDC data.The FDA previously authorized Pfizer booster doses for teenagers 12 to 15-years-old in January as the omicron variant swept the nation.

Source: SGX Masnet, The Business Times, Bloomberg, Channel NewsAsia, Reuters, CNBC, PSR

Keppel Corporation – 1Q22 see drag from Urban Development

Recommendation: BUY (Maintained), Last Done: S$6.66

Target price: S$7.07, Analyst: Terence Chua

– 1Q22 revenue of $2.1bn was below of our forecasts, at 23.5% of FY22e. The drag came from the Urban Development business.

– The update mentioned 1Q22 net profit was higher YoY, with improved performance from all its business segments except Urban Development. Keppel Offshore & Marine’s (KOM) recorded a significantly reduced net loss and was EBITDA positive.

– Significant progress made on advancing the sale of KOM legacy rigs and associated receivables, working towards definitive agreements by 30 April 2022.

– Maintain BUY with unchanged SOTP TP of S$7.07. We valued the Group based on the four new segments unveiled during Vision 2030 to better reflect the Group’s reporting segments going forward. Our TP translates to about 1.0x FY22e book value, in-line with its 5-year average. Catalysts expected from a successful resolution of its O&M unit.

POEMS Podcast: Let the Money Talk


Recent Podcasts:

Money Never Sleeps Ep 8

2Q22 Singapore Equity Strategy – SGX Company Insights Ep 49

Keppel Corp & Sembcorp Marine – SGX Company Insights Ep 48


Visit www.stocksbnb.com to view our research reports!



Join our Phillip Securities Research Telegram channel for the latest update on our stock coverage!

Click the link to join: https://t.me/stocksbnb

HK Reports – Read up on our Hong Kong reports here



Weekly Market Outlook: Netflix, TDCX, Keppel DC REIT, Phillip On The Ground, FAANGM, SG Weekly

Date: 25 April 2022

Click here for more on Market Outlook

Sign up for our webinars here, and be among the first to receive economy and market updates.


Phillip Research in 3 minutes: #29 – Keppel Corporation; Initiation

Click here for more videos on Phillip in 3 Mins

For any research-related matters, email: research@phillip.com.sg

For general enquiries, email: talktophillip@phillip.com.sg
or call 6531 1555.

Read the research report(s), available through the link(s) above, for complete information including important disclosures Important Information


The information contained in this email is provided to you for general information only and is not intended to create any binding legal relation. The information or opinions provided in this email do not constitute investment advice, a recommendation, an offer or solicitation to subscribe for, purchase or sell any investment product. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of this information. Investments are subject to investment risks including possible loss of the principal amount invested. The value of the product and the income from them may fall as well as rise.

You should obtain advice from a financial adviser before making a commitment to invest in any investment product or service. In the event that you choose not to obtain advice from a financial adviser, you should assess and consider whether the investment product or service is suitable for you before proceeding to invest.

Confidentiality Note

This e-mail and its attachment(s) may contain privileged or confidential information, which is intended only for the use of the recipient(s) named above. If you have received this message in error, please notify the sender immediately and delete all copies of it. If you are not the intended recipient, you must not read, use, copy, store, disseminate and/or disclose to any person this email and any of its attachment(s). PhillipCapital and its members will not accept legal responsibility for the contents of this message. Thank you for your cooperation.



    POEMS 3 App



    Call Back



    Chat with us

Contact us to Open an Account

Need Assistance? Share your Details and we’ll get back to you


This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  


Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com